Dexamethasone

Effect of secondary lymphoid tissue chemokine suppression on experimental ulcerative colitis in mice

H. Zhang, Zhang, X., Ding, X., Cao, W., Qu, L., and Zhou, G., Effect of secondary lymphoid tissue chemokine suppression on experimental ulcerative colitis in mice, vol. 13, pp. 3337-3345, 2014.

The secondary lymphoid tissue chemokine (CCL21) is closely associated with lymphoid homing and anti-tumor immune responses. CCL21 also has a chemotactic effect on intestinal lymphocytes. This study mainly focused on CCL21 expression in experimental ulcerative colitis and on the effects of CCL21 suppression on this disease in mice. The mouse colitis model was induced by dextran sulfate sodium (DSS) in 40 female BALB/c mice that were equally distributed into five groups: control, DSS, propylene glycol, triptolide (TL), and dexamethasone treatment groups.

Inhibitory effect of dexamethasone on Lewis mice lung cancer cells

Y. Geng, Wang, J., Jing, H., Wang, H. W., and Bao, Y. X., Inhibitory effect of dexamethasone on Lewis mice lung cancer cells, vol. 13, pp. 6827-6836, 2014.

Recent studies have found that glucocorticoids are closely associated with oncogenesis and the development of many types of tumors. The aim of this study was to observe the effect of dexamethasone on the growth and angiogenesis of transplanted Lewis lung carcinoma in mice. Lewis lung carcinoma cells were inoculated subcutaneously into the right axilla of C57BL/6 mice, and the mice were randomly divided into 3 groups: the control group, cisplatin group, and dexamethasone group.

Persistent glucocorticoid resistance in systemic lupus erythematosus patients during clinical remission

A. K. G. Melo, Melo, M. R., Saramago, A. B. A., Demartino, G., Souza, B. D. B., and Longui, C. A., Persistent glucocorticoid resistance in systemic lupus erythematosus patients during clinical remission, vol. 12, pp. 2010-2019, 2013.

Glucocorticoids (GCs) are key drugs in the treatment of systemic lupus erythematosus (SLE). GC dose reduction during remission is related to disease activity, GC dose used, length of treatment, and individual GC sensitivity. We compared GC receptor α (GRα) isoform and nuclear factor kappaB (NF-κB) messenger RNA quantitation and in vivo GC sensitivity between SLE patients during remission and healthy controls. We performed a cross-sectional study of 19 women aged 22-49 years, including 9 SLE patients in clinical remission taking ≤5 mg prednisone and 10 matched controls.

Quantitation of glucocorticoid receptor alpha and NF-κB pathway mRNA and its correlation with disease activity in rheumatoid arthritis patients

L. O. Cavalcante, Melo, M. R., Dinis, V. G., Castro, R. B., Souza, B. D. B., and Longui, C. A., Quantitation of glucocorticoid receptor alpha and NF-κB pathway mRNA and its correlation with disease activity in rheumatoid arthritis patients, vol. 9, pp. 2300-2310, 2010.

We measured NF-κB, IKK, c-Fos, and GRαmRNA expression and in vivo glucocorticoid sensitivity in patients with rheumatoid arthritis. A very low dose intravenous dexamethasone suppression test and real-time PCR quantitation of mRNA of these genes were performed on blood samples from 21 rheumatoid arthritis patients who were not on glucocorticoids during the previous four months and on blood samples from 20 healthy individuals.

Subscribe to Dexamethasone